false
English
Catalog
Best Practices and Research Advances in Thoracic O ...
Molecular Profiling: Research and Networking in th ...
Molecular Profiling: Research and Networking in the Region
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
Koichi Goto from the National Cancer Center outlines the LC-SCRAM-ASIA project, a genomic screening platform aiming to enhance precision medicine for lung cancer in Asian countries. Based in Japan, the platform is supported by numerous pharmaceutical companies and has seen significant participation from institutions and patients, resulting in a comprehensive genomic database. LC-SCRAM-ASIA has effectively identified various mutations and supported the approval of multiple targeted therapies, such as crosotinib and selpercatinib. The initiative has expanded its reach to several Asian Pacific countries, providing free genomic analysis and establishing a robust foundation for precision medicine in the region.
Asset Subtitle
Koichi Goto, MD, PhD
Keywords
genomic screening
precision medicine
lung cancer
LC-SCRAM-ASIA
targeted therapies
×
Please select your language
1
English
5
普通话
11
Dutch